Federal Health Officials Say Psychedelics’ Illegal Status Makes It Harder For Researchers To Study Them
MJ moment

Officials at two agencies within the National Institutes of Health (NIH) have acknowledged in a letter to two U.S. senators that federal prohibition makes it harder to study the benefits of psychedelics, requiring researchers to jump through additional regulatory hoops. The four-page letter, which was shared with Marijuana Moment, is a response to Sens. Brian Schatz (D-HI) and Cory Booker (D-NJ), who last month wrote to the heads of the NIH and the Food and Drug Administration (FDA) asking for an update on psychedelics research. The lawmakers argued that federal prohibition has stymied research into the efficacy and safety of the drugs despite growing evidence of their potential benefits. “Because psychedelic drugs are controlled substances,” the June 15 letter from the directors of the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH) says, “one additional regulatory consideration for basic and applied research using psychedelic drugs is that these studies must also follow Drug Enforcement (DEA) requirements, including registration, inspection, and certification of the drugs. These requirements apply to all psychedelic drugs, including natural or botanical products.” The officials said early research shows that psychedelics do have medical potential, but they signaled in the letter that they’re interested in enabling the development of new drugs that can give patients the medical benefits of substances like psilocybin but without what they called “negative side effects.” “Research on psychedelic drugs holds promise for uncovering mechanisms of illness and possible interventions,” they wrote, “ultimately leading to novel treatments with fewer side effects and lower potential for misuse.” The reply letter, signed by NIMH Director Joshua Gordon and NIDA Director Nora Volkow, acknowledges the therapeutic promise of psychedelics and other controlled substances—noting federal funding, for example, supporting research into whether psilocybin might improve smoking cessation or help treat chronic…

Excerpt only …
READ MORE BELOW
Source : Federal Health Officials Say Psychedelics’ Illegal Status Makes It Harder For Researchers To Study Them

reposted by Cannabis News World